[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100416561":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":31,"locations":38,"responsibleParty":61,"collaborators":30,"id":64,"slug":30,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":67,"acronym":68,"eligibilityCriteria":69,"healthyVolunteers":70,"sex":71,"minAge":72,"maxAge":73,"enrollmentInfo":74,"targetDuration":30,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":30,"overallStatus":41,"whyStopped":30,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":92},{"fullName":5,"class":6},"Yale University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Delta-9-Tetrahydrocannabinol (THC)","ACTIVE_COMPARATOR","4 mg vaporized THC will be administered.",[13],"Drug: Inhaled THC",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","Inhaled placebo (no active cannabinoids)",[19],"Drug: Placebo",[21,28],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Inhaled THC","4 mg inhaled THC",[9],[27],"Delta-9-Tetrahydrocannabinol",{"type":22,"name":15,"description":17,"armGroupLabels":29,"otherNames":30},[15],null,[32],{"name":33,"role":34,"phone":35,"phoneExt":36,"email":37},"Carly Hewes, BS","CONTACT","2039325711","7411","carly.hewes@yale.edu",[39],{"facility":40,"status":41,"city":42,"state":43,"zip":44,"country":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine","RECRUITING","West Haven","Connecticut","06516","United States",{"type":47,"coordinates":48},"Point",[49,50],-72.94705,41.27065,{"lat":50,"lon":49},[53,58],{"name":54,"role":34,"phone":55,"phoneExt":56,"email":57},"Christina Luddy, BS","203-932-5711","4549","christina.luddy@yale.edu",{"name":59,"role":60,"phone":30,"phoneExt":30,"email":30},"Mohini Ranganathan, MD","PRINCIPAL_INVESTIGATOR",{"type":60,"investigatorFullName":62,"investigatorTitle":63,"investigatorAffiliation":5,"oldNameTitle":30,"oldOrganization":30},"Mohini Ranganathan","Associate Professor of Psychiatry","100416561",false,"NCT04704271","Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study II","THC-Gender-II","Inclusion Criteria:\n\n* At least one lifetime exposure to cannabis\n* Good physical and mental health\n\nExclusion Criteria:\n\n* Cannabis naïve individuals\n* Major current or recent stressors",true,"ALL","18 Years","55 Years",{"count":75,"type":76},100,"ESTIMATED","INTERVENTIONAL",[79],"PHASE1","The purpose of the study is to characterize the acute effects of cannabinoids in women relative to men and to begin probing the mechanisms that may underlie gender differences.",[82],"Cannabis","2026-04-23",{"date":85,"type":86},"2026-04-29","ACTUAL",{"date":88,"type":86},"2019-10-09",{"date":90,"type":76},"2027-12-01",{"name":5,"class":6},1]